Sitemap - 2025 - The Microdose

The art of relinquishing control: 5 Questions for artist Matthew Palladino

Live from Psychedelic Science 2025

Psychedelic Science 2025

Live from Psychedelic Science 2025: A dispatch from Denver

Shamanism and psychedelics: 5 Questions for Manvir Singh

Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing

MDMA for narcissism? 5 Questions for psychoanalyst and psychiatrist Alexa Albert

Ketamine company sues newspaper; atai to merge with Beckley Psytech; and Oregon disabilities case continues

Psychedelic traditions from Africa and the African diaspora: 5 Questions for Darren Le Baron

Meta suspends numerous psychedelics-related accounts; California psilocybin pilot program bill dies; and Preliminary results from Gilgamesh’s phase 2 clinical trial

FDA commissioner says psychedelics are a “top priority,” and Connecticut legislators just barely pass decrim bill

Colorado’s Natural Medicine program launches, and Texas goes all in on psychedelics

Florida legislature votes to ban psilocybin mushroom spores and Colorado legislators pass data collection bill; Federal leaders continue advocacy of psychedelics

"Recovery is whatever makes you feel less bad": 5 Questions for The Small Bow founder A.J. Daulerio

RFK Jr.’s first acid trip, and federal health leaders appear to be keen on psychedelics; The rise of ketamine use disorder

Treating patients with challenging psychedelics experiences: 5 Questions for psychiatrist Azin Bekhrad

Increase in psilocybin use — and in poison control reports; Could classic psychedelics reduce stress-induced inflammation?; A study of Nova festival survivors

A non-hallucinogenic LSD analog?; Texas committee advances ibogaine research grant bill; Psyence bets on ibogaine

Taking the drug out of the trip: 5 Questions for Stanford anesthesiologist and neuroscientist Boris Heifets

New Mexico becomes third state to establish a state psilocybin program; Federal bill to improve veteran access to psychedelics; DOGE eliminates 10,000 HHS positions

Colorado’s first licensed healing center: 5 Questions for The Center Origin co-founder and clinical director Mikki Vogt

Veterans Affairs Secretary vows to “get to the yes” on psychedelics; Colorado licenses first psilocybin healing center; Perceived effects of psychedelics on sex

Psilocybin for anorexia: 5 Questions for researcher Marissa Raymond-Flesch

Minnesota introduces psilocybin decriminalization bill, and wide-ranging Florida bill would ban psilocybin mushroom spores and mycelia; One dose of psilocybin equivalent to placebo in decreasing alcoh

The power of “know-cebo”: 5 Questions for data scientist Balázs Szigeti

New Mexico poised to become third state with a regulated psilocybin program; Low doses of LSD for ADHD no more effective than placebo; State bill bonanza continues

Taking ayahuasca with mom: 5 Questions for NFL safety Jordan Poyer

Not everything’s bigger in Texas

“You can be humbled by a trip”: 5 Questions for Zen Buddhist priest Kokyo Henkel

New bills in CT and VT, bills advance in AZ and MO, and a NV resolution; Oregon psilocybin center wins permit appeal; and A bad trip case study

Foragers and “noccers”: 5 Questions for mycologist and author Eugenia Bone

New California bills focus on veterans; the State of Psychedelics; Death penalty for dealers?

What do people see when they’re tripping?: 5 Questions for neuroscientist Sean Noah

Federal court sides with DEA’s denial of access to psilocybin for terminally ill patients; COMPASS trigger law in Kansas; Could Arizona be first on ibogaine?

RFK Jr. confirmed as Trump’s health secretary; Federal lawsuit against Oregon’s psilocybin program; Changing psilocybin laws in India?

Spiritual crisis and psychedelics: 5 Questions for anthropologist Aidan Seale-Feldman

A flurry of new state bills; Preliminary synthetic 5-MeO-DMT phase II results; Lessons from a suicide

Black Psychedelia: 5 Questions for author Nick Powers

Kennedy hearings; U.S. Embassy in Peru & Costa Rica Ministry of Health warn against ayahuasca use; Proposed legislation would change OR & CO psilocybin programs

Sex & Psychedelics: 5 Questions for magazine founder Sura Hertzberg

FDA expands Spravato approval, and the Future of RFK Jr. and federal agencies' approach to psychedelics in limbo

Lykos board shake-up; Colorado’s Natural Medicine program weighs new at-home facilitation rules; LSD for mind control

Ayahuasca in China, Peru, and Australia: 5 Questions for anthropologist Alex Gearin

Billionaire proposes plan to take control of Lykos; Colorado’s Natural Medicine Program launches; Could Minnesota be next?; Mail-order ketamine for injection

The risks of mixing ayahuasca and SSRIs: 5 Questions for UCLA psychiatry professor Charles Grob

What is one psychedelics story you will be following in 2025?

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts